Midiagnostics raised €30M in a Series D+ round in Dec 2024. The company is based in Leuven, Belgium. Investors in the round: Alychlo, Pamica, Thermo Fisher Scientific Inc. and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €30M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
